The Kase Group is pleased to present a rare opportunity to acquire a state-of-the-art facility in Roseville, Minnesota. The property is secured by an 11+ year absolute NNN lease, offering zero landlord responsibilities and long-term stability. The lease is corporately guaranteed by Cyellectis S.A., a publicly traded French pharmaceutical company (NASDAQ: CLLS), and features 7.5% rent increases every five years, along with four additional five-year renewal options. Completed in 2018, the property is a Class A facility situated on an 11-acre corporate campus. It includes advanced laboratory and research space, a test kitchen, greenhouse, and outdoor demonstration plots, making it a mission-critical location for Cibus, a leader in precision gene editing for agriculture. The property is conveniently located just five minutes from Downtown Minneapolis and eight minutes from Downtown St. Paul, with immediate access to I-35W, which carries more than 139,000 vehicles per day. The property is part of a 280-acre master-planned redevelopment featuring high-density residential, Class A office and industrial space, retail, and hospitality. It is supported by strong demographics, including more than 285,000 residents within a five-mile radius and a daytime population of over 238,000 employees. Average household income exceeds $99,000 within one mile. Nearby, Rosedale Center attracts more than 14 million visitors annually following a $100 million renovation. The area also offers a wide variety of restaurants, hotels, entertainment options, and outdoor recreation at Langton Park.